newsfilter
← Latest News
CNBC·

BioNTech buys German site from Novartis to boost vaccine output

Germany's BioNTech is purchasing a German biotech production site from Swiss drugs giant Novartis to boost output of the coronavirus vaccine hopeful it is developing with Pfizer.